The renewed strength in TAVR, following a slowdown last year tied to heart team capacity challenges at hospitals, prompted ...

Edwards TAVR segment reached $1.1bn in Q2 2025, up 8.9% compared to Q2 2024, while its heart valve segment increased by 61.9% ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2025. Recent Highlights. Q2 sales g ...

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Edwards Lifesciences stock surged late Thursday after the medtech hiked its outlook following a key setback for rival Boston ...

Edwards Lifesciences reported Street-beating Q2 results, upping the lower end of its full-year sales guidance.

Edwards Lifesciences Corp (EW) reports a 10.6% sales increase and raises full-year guidance, driven by robust performance in ...

Background Current risk scores inadequately predict long-term mortality after transcatheter aortic valve replacement (TAVR), ...

A Naples woman nearly lost her life to an aortic aneurysm during dance class - with almost no warning signs. Dr. Stapleton ...

In a surgical first, doctors have replaced a heart valve through a small neck incision using robotic assistance, avoiding the ...

However, this is the past; this article details the present and the near future. Several platforms have been evaluated in ...